Literature DB >> 9144342

Plasminogen activator system in osteoclasts.

J N Yang1, E H Allan, G I Anderson, T J Martin, C Minkin.   

Abstract

To determine which genes of the plasminogen activator (PA) system were expressed in osteoclasts, RNA extracted from microisolated mouse osteoclasts was used as template for reverse transcribed polymerase chain reaction (RT-PCR) with gene-specific primer pairs. Using this approach, the expression of RNAs for tissue-type plasminogen activator, urokinase-type plasminogen activator, plasminogen activator inhibitor-1, plasminogen activator inhibitor-2, protease nexin, and urokinase receptor isoform 1 (uPAR1) were detected in mouse osteoclasts. The expression of uPAR RNA in osteoclasts was confirmed by in situ hybridization with a uPAR1 probe. RNA encoding the uPAR isoform 2 was not detected in mouse osteoclasts, but a novel unspliced uPAR RNA variant was detected in these cells. The novel uPAR variant and uPAR1 RNA were also detected in mouse calvarial osteoblasts, kidney, muscle, and the mouse macrophage cell line J774A.1 by RT-PCR. The presence of RNAs for most of the components of the PA system in osteoclasts suggests that it may have a functional role in this cell type.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144342     DOI: 10.1359/jbmr.1997.12.5.761

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer.

Authors:  K Ichiki; N Mitani; Y Doki; H Hara; T Misaki; I Saiki
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization.

Authors:  S M Nordstrom; S M Carleton; W L Carson; M Eren; C L Phillips; D E Vaughan
Journal:  Bone       Date:  2007-08-17       Impact factor: 4.398

3.  Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology.

Authors:  Amélie E Coudert; Andrea Del Fattore; Céline Baulard; Robert Olaso; Corinne Schiltz; Corinne Collet; Anna Teti; Marie-Christine de Vernejoul
Journal:  Lab Invest       Date:  2013-12-16       Impact factor: 5.662

4.  Manganese superoxide dismutase is required to maintain osteoclast differentiation and function under static force.

Authors:  Tao Guo; Liqiang Zhang; Anna Konermann; Hong Zhou; Fang Jin; Wenjia Liu
Journal:  Sci Rep       Date:  2015-01-26       Impact factor: 4.379

5.  The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice.

Authors:  Naoyuki Kawao; Yukinori Tamura; Yoshitaka Horiuchi; Katsumi Okumoto; Masato Yano; Kiyotaka Okada; Osamu Matsuo; Hiroshi Kaji
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

6.  TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma.

Authors:  K Murakami; T Yamaura; K Suda; S Ohie; J Shibata; T Toko; Y Yamada; I Saiki
Journal:  Jpn J Cancer Res       Date:  1999-11

7.  A small-molecule PAI-1 inhibitor prevents bone loss by stimulating bone formation in a murine estrogen deficiency-induced osteoporosis model.

Authors:  Guangwen Jin; Alkebaier Aobulikasimu; Jinying Piao; Zulipiya Aibibula; Daisuke Koga; Shingo Sato; Hiroki Ochi; Kunikazu Tsuji; Tetsuo Nakabayashi; Toshio Miyata; Atsushi Okawa; Yoshinori Asou
Journal:  FEBS Open Bio       Date:  2018-02-16       Impact factor: 2.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.